Skip to main content
OpenTrials

Clinical trial condition

Endometrial Neoplasms

Explore clinical trials studying Endometrial Neoplasms. Study availability and eligibility vary by location and protocol.

1,001 public trials 299 recruiting studies
Refine in advanced search Browse all conditions

Endometrial Neoplasms trial results

Recruiting

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

NCT06463028

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +31 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of California, San Francisco (UCSF) San Francisco, California, United States
  • Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
  • Florida Cancer Specialists, North St. Petersburg, Florida, United States
View all 18 locations
View Trial Details
Recruiting

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

NCT05856981

Conditions
Adenocarcinoma, Bronchial Neoplasms, CRC, Colorectal Cancer, +47 more
Locations
  • Henry Ford Cancer Institute Detroit, Michigan, United States
  • Washington University Medical Campus St Louis, Missouri, United States
  • Gabrail Cancer & Research Center Canton, Ohio, United States
  • Virginia Cancer Specialists Fairfax, Virginia, United States
View Trial Details
Recruiting

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

NCT06774963

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Biliary Tract Cancer, +37 more
Locations
  • Hoag Family Cancer Institute Newport Beach, California, United States
  • St. Elizabeth Healthcare Edgewood, Kentucky, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University, Siteman Cancer Center St Louis, Missouri, United States
View all 14 locations
View Trial Details
Recruiting

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

NCT06943521

Conditions
Adenocarcinoma, Adnexal Diseases, Biliary Tract Cancer, +75 more
Locations
  • University of Southern California Los Angeles, California, United States
  • START Midwest Grand Rapids, Michigan, United States
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer

NCT06795009

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +11 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • University of New Mexico Albuquerque, New Mexico, United States
  • University of Oklahoma Oklahoma City, Oklahoma, United States
View Trial Details
Recruiting

Study of GV20-0251 in Participants With Solid Tumor Malignancies

NCT07070518

Conditions
Adenocarcinoma, Adult Refractory Cancer, Bronchial Neoplasms, +44 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Shanghai Pulmonary Hospital Shanghai, Shanghai Municipality, China
View Trial Details
Recruiting

DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition

NCT05770102

Conditions
Cancer, Colonic Diseases, Colorectal Neoplasms, +37 more
Locations
  • Belfast City Hospital Belfast, United Kingdom
  • University Hospital Birmingham Birmingham, United Kingdom
  • Birmingham Children's Hospital Birmingham, United Kingdom
  • Bristol Royal Hospital for Children Bristol, United Kingdom
View all 27 locations
View Trial Details

Related conditions